Ursodeoxycholic acid for primary biliary cirrhosis

被引：44

作者：

Lindor, KD

Poupon, R

Heathcote, EJ

Therneau, T

机构：

[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

[2] Serv Hepatol, APHP, Paris, France

[3] INSERM, U370, Paris, France

[4] Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Toronto, ON M5T 2S8, Canada

来源：

LANCET | 2000年 / 355卷 / 9204期

关键词：

D O I：

10.1016/S0140-6736(05)72401-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：657 / 658

页数：2

共 5 条

[1] METAANALYSIS IN CLINICAL-TRIALS [J].

DERSIMONIAN, R ;

LAIRD, N .

CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188

[2] Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis [J].

Goulis, J ;

Leandro, G ;

Burroughs, AK .

LANCET, 1999, 354 (9184) :1053-1060

[3]

Kilmurry MR, 1996, HEPATOLOGY, V23, P1148

[4] URSODEOXYCHOLIC ACID IN THE TREATMENT OF PRIMARY BILIARY-CIRRHOSIS [J].

LINDOR, KD ;

DICKSON, ER ;

BALDUS, WP ;

JORGENSEN, RA ;

LUDWIG, J ;

MURTAUGH, PA ;

HARRISON, JM ;

WIESNER, RH ;

ANDERSON, ML ;

LANGE, SM ;

LESAGE, G ;

ROSSI, SS ;

HOFMANN, AF .

GASTROENTEROLOGY, 1994, 106 (05) :1284-1290

[5]

PARES A, IN PRESS J HEPATOL

← 1 →